{"id":"https://openalex.org/W2071069178","doi":"https://doi.org/10.1158/1078-0432.ccr-13-3141","title":"Molecular Pathways: The Immunogenic Effects of Platinum-Based Chemotherapeutics","display_name":"Molecular Pathways: The Immunogenic Effects of Platinum-Based Chemotherapeutics","publication_year":2014,"publication_date":"2014-05-29","ids":{"openalex":"https://openalex.org/W2071069178","doi":"https://doi.org/10.1158/1078-0432.ccr-13-3141","mag":"2071069178","pmid":"https://pubmed.ncbi.nlm.nih.gov/24879823"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.ccr-13-3141","doi":"https://doi.org/10.1158/1078-0432.ccr-13-3141","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-13-3141","pdf_url":"https://clincancerres.aacrjournals.org/content/clincanres/20/11/2831.full.pdf","source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2071069178"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://clincancerres.aacrjournals.org/content/clincanres/20/11/2831.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5074215366","display_name":"Stanleyson V. Hato","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I177877127","display_name":"The University of Western Australia","ror":"https://ror.org/047272k79","country_code":"AU","type":"education","lineage":["https://openalex.org/I177877127"]},{"id":"https://openalex.org/I2802934949","display_name":"Radboud University Medical Center","ror":"https://ror.org/05wg1m734","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802934949"]}],"countries":["AU","NL"],"is_corresponding":false,"raw_author_name":"Stanleyson V. Hato","raw_affiliation_strings":["Authors' Affiliations: Departments of 1Tumor Immunology and 2Medical Oncology, Radboud University Medical Centre and Nijmegen Centre for Molecular Life Sciences, Nijmegen, the Netherlands and 3National Centre for Asbestos Related Diseases, The University of Western Australia, Perth, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Departments of 1Tumor Immunology and 2Medical Oncology, Radboud University Medical Centre and Nijmegen Centre for Molecular Life Sciences, Nijmegen, the Netherlands and 3National Centre for Asbestos Related Diseases, The University of Western Australia, Perth, Australia","institution_ids":["https://openalex.org/I177877127","https://openalex.org/I2802934949"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006244599","display_name":"Andrea Khong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I177877127","display_name":"The University of Western Australia","ror":"https://ror.org/047272k79","country_code":"AU","type":"education","lineage":["https://openalex.org/I177877127"]},{"id":"https://openalex.org/I2802934949","display_name":"Radboud University Medical Center","ror":"https://ror.org/05wg1m734","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802934949"]}],"countries":["AU","NL"],"is_corresponding":false,"raw_author_name":"Andrea Khong","raw_affiliation_strings":["Authors' Affiliations: Departments of 1Tumor Immunology and 2Medical Oncology, Radboud University Medical Centre and Nijmegen Centre for Molecular Life Sciences, Nijmegen, the Netherlands and 3National Centre for Asbestos Related Diseases, The University of Western Australia, Perth, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Departments of 1Tumor Immunology and 2Medical Oncology, Radboud University Medical Centre and Nijmegen Centre for Molecular Life Sciences, Nijmegen, the Netherlands and 3National Centre for Asbestos Related Diseases, The University of Western Australia, Perth, Australia","institution_ids":["https://openalex.org/I177877127","https://openalex.org/I2802934949"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054219763","display_name":"I. Jolanda M. de Vries","orcid":"https://orcid.org/0000-0002-8653-4040","observed_orcids":["https://orcid.org/0000-0002-8653-4040"]},"institutions":[{"id":"https://openalex.org/I177877127","display_name":"The University of Western Australia","ror":"https://ror.org/047272k79","country_code":"AU","type":"education","lineage":["https://openalex.org/I177877127"]},{"id":"https://openalex.org/I2802934949","display_name":"Radboud University Medical Center","ror":"https://ror.org/05wg1m734","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802934949"]}],"countries":["AU","NL"],"is_corresponding":false,"raw_author_name":"I. Jolanda M. de Vries","raw_affiliation_strings":["Authors' Affiliations: Departments of 1Tumor Immunology and 2Medical Oncology, Radboud University Medical Centre and Nijmegen Centre for Molecular Life Sciences, Nijmegen, the Netherlands and 3National Centre for Asbestos Related Diseases, The University of Western Australia, Perth, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Departments of 1Tumor Immunology and 2Medical Oncology, Radboud University Medical Centre and Nijmegen Centre for Molecular Life Sciences, Nijmegen, the Netherlands and 3National Centre for Asbestos Related Diseases, The University of Western Australia, Perth, Australia","institution_ids":["https://openalex.org/I177877127","https://openalex.org/I2802934949"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5007519821","display_name":"Willem Joost Lesterhuis","orcid":"https://orcid.org/0000-0002-2718-276X","observed_orcids":["https://orcid.org/0000-0002-2718-276X"]},"institutions":[{"id":"https://openalex.org/I177877127","display_name":"The University of Western Australia","ror":"https://ror.org/047272k79","country_code":"AU","type":"education","lineage":["https://openalex.org/I177877127"]},{"id":"https://openalex.org/I2802934949","display_name":"Radboud University Medical Center","ror":"https://ror.org/05wg1m734","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802934949"]}],"countries":["AU","NL"],"is_corresponding":true,"raw_author_name":"W. Joost Lesterhuis","raw_affiliation_strings":["Authors' Affiliations: Departments of 1Tumor Immunology and 2Medical Oncology, Radboud University Medical Centre and Nijmegen Centre for Molecular Life Sciences, Nijmegen, the Netherlands and 3National Centre for Asbestos Related Diseases, The University of Western Australia, Perth, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Departments of 1Tumor Immunology and 2Medical Oncology, Radboud University Medical Centre and Nijmegen Centre for Molecular Life Sciences, Nijmegen, the Netherlands and 3National Centre for Asbestos Related Diseases, The University of Western Australia, Perth, Australia","institution_ids":["https://openalex.org/I177877127","https://openalex.org/I2802934949"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5007519821"],"corresponding_institution_ids":["https://openalex.org/I177877127","https://openalex.org/I2802934949"],"apc_list":null,"apc_paid":null,"fwci":2.2315,"has_fulltext":true,"cited_by_count":482,"citation_normalized_percentile":{"value":0.91766724,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":97,"max":100},"biblio":{"volume":"20","issue":"11","first_page":"2831","last_page":"2837"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.7782999873161316,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.7782999873161316,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.1348000019788742,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10163","display_name":"Metal complexes synthesis and properties","score":0.062300000339746475,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.9309999942779541},{"id":"https://openalex.org/keywords/carboplatin","display_name":"carboplatin","score":1.0},{"id":"https://openalex.org/keywords/oxaliplatin","display_name":"oxaliplatin","score":1.0},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.7039999961853027},{"id":"https://openalex.org/keywords/immunogenic-cell-death","display_name":"immunogenic cell death","score":0.7710000276565552},{"id":"https://openalex.org/keywords/calreticulin-exposure","display_name":"calreticulin exposure","score":0.8870000243186951},{"id":"https://openalex.org/keywords/atp-release","display_name":"ATP release","score":0.7639999985694885},{"id":"https://openalex.org/keywords/hmgb1","display_name":"HMGB1","score":0.9580000042915344},{"id":"https://openalex.org/keywords/stat-signaling","display_name":"STAT signaling","score":0.9070000052452087},{"id":"https://openalex.org/keywords/pd-1-ligands","display_name":"PD-1 ligands","score":0.7160000205039978},{"id":"https://openalex.org/keywords/mannose-6-phosphate-receptor","display_name":"mannose 6-phosphate receptor","score":0.9909999966621399},{"id":"https://openalex.org/keywords/immunoadjuvant","display_name":"immunoadjuvant","score":0.7979999780654907},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.6729999780654907}],"concepts":[{"id":"https://openalex.org/C2781451048","wikidata":"https://www.wikidata.org/wiki/Q415588","display_name":"Carboplatin","level":4,"score":0.657179057598114},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.6383655667304993},{"id":"https://openalex.org/C2780962732","wikidata":"https://www.wikidata.org/wiki/Q422327","display_name":"Oxaliplatin","level":4,"score":0.6221210360527039},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.610034704208374},{"id":"https://openalex.org/C2777877232","wikidata":"https://www.wikidata.org/wiki/Q17144704","display_name":"Immunogenic cell death","level":4,"score":0.5827407836914062},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5124819278717041},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.48622503876686096},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.46706753969192505},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.44639524817466736},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.4296892285346985},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.40404924750328064},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.38547927141189575},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3310183882713318},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.2528543472290039},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2342221736907959},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2190580666065216},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D017671","descriptor_name":"Platinum Compounds","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.1158/1078-0432.ccr-13-3141","doi":"https://doi.org/10.1158/1078-0432.ccr-13-3141","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-13-3141","pdf_url":"https://clincancerres.aacrjournals.org/content/clincanres/20/11/2831.full.pdf","source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},{"id":"pmh:oai:pure.atira.dk:openaire/fbc31a9c-360b-491a-948a-e0e202073f1a","doi":null,"is_oa":true,"landing_page_url":"https://research-repository.uwa.edu.au/en/publications/fbc31a9c-360b-491a-948a-e0e202073f1a","pdf_url":null,"source":{"id":"https://openalex.org/S4306402492","display_name":"UWA Profiles and Research Repository (UWA)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I177877127","host_organization_name":"The University of Western Australia","host_organization_lineage":["https://openalex.org/I177877127"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hato, S V, Khong, A, De Vries, I J M & Lesterhuis, W 2014, 'Molecular pathways: the immunogenic effects of platinum-based chemotherapeutics', Clinical Cancer Research, vol. 20, no. 11, pp. 2831-2837. https://doi.org/10.1158/1078-0432.CCR-13-3141","raw_type":"info:eu-repo/semantics/article"},{"id":"pmid:24879823","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24879823","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Journal Article"},{"id":"pmh:oai:repository.ubn.ru.nl:2066/137467","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/2066/137467","pdf_url":null,"source":{"id":"https://openalex.org/S4306401067","display_name":"Radboud Repository (Radboud University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I145872427","host_organization_name":"Radboud University Nijmegen","host_organization_lineage":["https://openalex.org/I145872427"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Article / Letter to editor"},{"id":"pmh:ru:oai:repository.ubn.ru.nl:2066/137467","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/2066/137467","pdf_url":null,"source":{"id":"https://openalex.org/S4306401067","display_name":"Radboud Repository (Radboud University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I145872427","host_organization_name":"Radboud University Nijmegen","host_organization_lineage":["https://openalex.org/I145872427"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Clinical Cancer Research, 20, 2831 - 7","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.ccr-13-3141","doi":"https://doi.org/10.1158/1078-0432.ccr-13-3141","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-13-3141","pdf_url":"https://clincancerres.aacrjournals.org/content/clincanres/20/11/2831.full.pdf","source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2071069178.pdf","grobid_xml":"https://content.openalex.org/works/W2071069178.grobid-xml"},"referenced_works_count":63,"referenced_works":["https://openalex.org/W1814576137","https://openalex.org/W1965130745","https://openalex.org/W1967329857","https://openalex.org/W1969158270","https://openalex.org/W1974176583","https://openalex.org/W1976777395","https://openalex.org/W1978896388","https://openalex.org/W1979908884","https://openalex.org/W1980889809","https://openalex.org/W1980980429","https://openalex.org/W1983802200","https://openalex.org/W1984198270","https://openalex.org/W1986085836","https://openalex.org/W1986406178","https://openalex.org/W1988063766","https://openalex.org/W1993263049","https://openalex.org/W1996630968","https://openalex.org/W1997322465","https://openalex.org/W1997446529","https://openalex.org/W2006826463","https://openalex.org/W2009840402","https://openalex.org/W2012743071","https://openalex.org/W2014951111","https://openalex.org/W2016612145","https://openalex.org/W2020890328","https://openalex.org/W2029646533","https://openalex.org/W2033708244","https://openalex.org/W2036166614","https://openalex.org/W2038528969","https://openalex.org/W2043497955","https://openalex.org/W2043610941","https://openalex.org/W2048397219","https://openalex.org/W2056893124","https://openalex.org/W2060169839","https://openalex.org/W2068951506","https://openalex.org/W2072758081","https://openalex.org/W2080569603","https://openalex.org/W2083818823","https://openalex.org/W2090750060","https://openalex.org/W2091103707","https://openalex.org/W2093424661","https://openalex.org/W2096539359","https://openalex.org/W2098414192","https://openalex.org/W2101898479","https://openalex.org/W2103707167","https://openalex.org/W2106949373","https://openalex.org/W2111521405","https://openalex.org/W2115663377","https://openalex.org/W2120426523","https://openalex.org/W2125529404","https://openalex.org/W2127152090","https://openalex.org/W2130177169","https://openalex.org/W2134661616","https://openalex.org/W2138250841","https://openalex.org/W2152702691","https://openalex.org/W2155599713","https://openalex.org/W2160410413","https://openalex.org/W2163666497","https://openalex.org/W2461149012","https://openalex.org/W2952165521","https://openalex.org/W4234560968","https://openalex.org/W6671960305","https://openalex.org/W6718518432"],"related_works":["https://openalex.org/W2964181584","https://openalex.org/W2995643185","https://openalex.org/W4309506462","https://openalex.org/W3026943241","https://openalex.org/W4243887289","https://openalex.org/W4249013001","https://openalex.org/W2321253760","https://openalex.org/W2333928956","https://openalex.org/W3005620521","https://openalex.org/W2033708244"],"abstract_inverted_index":{"The":[0],"platinum-based":[1],"drugs":[2,80,173],"cisplatin,":[3],"carboplatin,":[4],"and":[5,71,109,113,119,133,139,202,209],"oxaliplatin":[6],"belong":[7],"to":[8,30,41,45,157,206],"the":[9,32,75,85,122,148,180,183,189,204,210,216],"most":[10],"widely":[11],"used":[12],"chemotherapeutics":[13,153],"in":[14,54,212],"oncology,":[15],"showing":[16],"clinical":[17,140,190],"efficacy":[18,150],"against":[19],"many":[20],"solid":[21],"tumors.":[22],"Their":[23],"main":[24],"mechanism":[25,166],"of":[26,34,74,78,84,93,97,101,107,111,121,128,147,151,167,169,186,215,219],"action":[27,168],"is":[28],"believed":[29],"be":[31,155],"induction":[33,96],"cancer":[35,102,172],"cell":[36,103],"apoptosis":[37],"as":[38,69,194],"a":[39,195],"response":[40,125],"their":[42],"covalent":[43],"binding":[44],"DNA.":[46],"In":[47],"recent":[48],"years,":[49],"this":[50,164],"picture":[51],"has":[52],"increased":[53],"complexity,":[55],"based":[56],"on":[57,182],"studies":[58,141,162,208],"indicating":[59],"that":[60,72,143],"cellular":[61],"molecules":[62],"other":[63],"than":[64],"DNA":[65],"may":[66,154],"potentially":[67],"act":[68],"targets,":[70],"part":[73,146],"antitumor":[76,149],"effects":[77,90,185,218],"platinum":[79,152,193],"occurs":[81],"through":[82,105,126],"modulation":[83,92,127],"immune":[86,124,158,199],"system.":[87],"These":[88],"immunogenic":[89,99,184],"include":[91],"STAT":[94],"signaling;":[95],"an":[98],"type":[100],"death":[104,130],"exposure":[106],"calreticulin":[108],"release":[110],"ATP":[112],"high-mobility":[114],"group":[115],"protein":[116],"box-1":[117],"(HMGB-1);":[118],"enhancement":[120],"effector":[123],"programmed":[129],"receptor":[131,135],"1-ligand":[132],"mannose-6-phosphate":[134],"expression.":[136],"Both":[137],"basic":[138],"indicate":[142],"at":[144],"least":[145],"due":[156],"potentiating":[159],"mechanisms.":[160],"Clinical":[161],"exploiting":[163],"novel":[165],"these":[170,207,220],"old":[171],"have":[174],"been":[175],"initiated.":[176],"Here,":[177],"we":[178],"review":[179],"literature":[181],"platinum,":[187],"summarize":[188],"advances":[191],"using":[192],"cytotoxic":[196],"compound":[197],"with":[198],"adjuvant":[200],"properties,":[201],"discuss":[203],"limitations":[205],"gaps":[211],"our":[213],"understanding":[214],"immunologic":[217],"drugs.":[221],"Clin":[222],"Cancer":[223],"Res;":[224],"20(11);":[225],"2831-7.":[226],"\u00a92014":[227],"AACR.":[228]},"counts_by_year":[{"year":2026,"cited_by_count":36},{"year":2025,"cited_by_count":33},{"year":2024,"cited_by_count":39},{"year":2023,"cited_by_count":42},{"year":2022,"cited_by_count":53},{"year":2021,"cited_by_count":55},{"year":2020,"cited_by_count":66},{"year":2019,"cited_by_count":45},{"year":2018,"cited_by_count":40},{"year":2017,"cited_by_count":21},{"year":2016,"cited_by_count":25},{"year":2015,"cited_by_count":21},{"year":2014,"cited_by_count":5}],"updated_date":"2026-11-15T12:55:33.944570","created_date":"2016-06-24T00:00:00"}
